The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALECTOR INC COM 014442107 20,432 980,894 SH   SOLE   980,894 0 0
BEAM THERAPEUTICS INC COM 07373V105 4,007 31,131 SH   SOLE   31,131 0 0
CONSTELLATION PHARMCETICLS I COM 210373106 18,736 554,325 SH   SOLE   554,325 0 0
DENALI THERAPEUTICS INC COM 24823R105 25,395 323,749 SH   SOLE   323,749 0 0
FIRST FINL BANCORP OH COM 320209109 4,102 173,576 SH   SOLE   173,576 0 0
FOGHORN THERAPEUTICS INC COM 344174107 13,458 1,261,261 SH   SOLE   1,261,261 0 0
23ANDME HOLDING CO CLASS A COM 90138Q108 119,742 10,243,119 SH   SOLE   10,243,119 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 29,449 1,493,349 SH   SOLE   1,493,349 0 0
NURIX THERAPEUTICS INC COM 67080M103 4,097 154,426 SH   SOLE   154,426 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 17,632 996,734 SH   SOLE   996,734 0 0
PINDUODUO INC SPONSORED ADS 722304102 1,246 9,806 SH   SOLE   9,806 0 0
PMV PHARMACEUTICALS INC COM 69353Y103 133,520 3,908,677 SH   SOLE   3,908,677 0 0
RAPT THERAPEUTICS INC COM 75382E109 23,391 735,801 SH   SOLE   735,801 0 0
SNOWFLAKE INC CL A 833445109 11,397 47,136 SH   SOLE   47,136 0 0
VIR BIOTECHNOLOGY INC COM 92764N102 1,223 25,866 SH   SOLE   25,866 0 0